Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials

Abstract Background Given the broad definition of an acute exacerbation of IPF, it is likely that acute exacerbations are heterogeneous in their aetiology, severity and clinical course. We used pooled data from the INPULSIS® trials of nintedanib versus placebo to investigate whether acute exacerbati...

詳細記述

書誌詳細

主要な著者:	Michael Kreuter, Harald Koegler, Matthias Trampisch, Silke Geier, Luca Richeldi
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2019-04-01
シリーズ:	Respiratory Research
主題:	Nintedanib Tyrosine kinase inhibitor Serious adverse events Disease progression Treatment outcome
オンライン･アクセス:	http://link.springer.com/article/10.1186/s12931-019-1037-7
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!